On CD28/CD40 ligand costimulation, common γ-chain signals, and the alloimmune response

被引:20
作者
Demirci, G
Gao, WD
Zheng, XX
Malek, TR
Strom, TB
Li, XC [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Immunol, Boston, MA 02215 USA
[2] Univ Miami, Dept Microbiol & Immunol, Miami, FL 33101 USA
关键词
D O I
10.4049/jimmunol.168.9.4382
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation and robust expansion of naive T cells often require T cell costimulatory signals and T cell growth factors. However, the precise growth and costimulation requirements for activation and expansion of CD4(+) and CD8(+) T cells in vivo in allograft response are still not clearly defined. In the present study, we critically examined the role of CD28/CD40 ligand (CD40L) costimulation and the common gamma-chain (gamma(c)) signals, a shared signaling component by receptors for all known T cell growth factors (i.e., IL-2, IL-4, IL-7, IL-9, IL-15, IL-21), in activation and expansion of CD4(+) and CD8(+) T cells in the allogeneic hosts. We found that CD28/CD40L costimulation and the gamma(c) signals are differentially involved in proliferation and clonal expansion of CD4(+) and CD8(+) T cells in response to alloantigen stimulation. CD8(+) T cells are highly dependent on the gamma(c) signals for survival, expansion, and functional maturation, whereas in vivo expansion of alloreactive CD4(+) T cells is largely gamma(c) independent. T cell costimulation via CD28 and CD40L, however, is necessary and sufficient for activation and expansion of CD4(+) T cells in vivo. In a skin transplant model, blocking both CD28/CD40L and the gamma(c) pathways induced prolonged skin allograft survival. Our study provides critical insights that the CD4 and CD8 compartments are most likely governed by distinct mechanisms in vivo, and targeting both costimulatory and gamma(c) signals may be highly effective in certain cytopathic conditions involving activation of both CD4(+) and CD8(+) T cells.
引用
收藏
页码:4382 / 4390
页数:9
相关论文
共 49 条
[1]   T cell activation and the cytoskeleton [J].
Acuto, O ;
Cantrell, D .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :165-+
[2]   Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses [J].
Andreasen, SO ;
Christensen, JE ;
Marker, O ;
Thomsen, AR .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3689-3697
[3]   Cutting edge:: The common γ-chain is an indispensable subunit of the IL-21 receptor complex [J].
Asao, H ;
Okuyama, C ;
Kumaki, S ;
Ishii, N ;
Tsuchiya, S ;
Foster, D ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :1-5
[4]  
Buhlmann JE, 1999, J IMMUNOL, V162, P4373
[5]   Infectious tolerance [J].
Cobbold, S ;
Waldmann, H .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :518-524
[6]   Interleukin 15: biology and relevance to human disease [J].
Fehniger, TA ;
Caligiuri, MA .
BLOOD, 2001, 97 (01) :14-32
[7]   An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection [J].
Ferrari-Lacraz, S ;
Zheng, XX ;
Kim, YS ;
Li, YS ;
Maslinski, W ;
Li, XC ;
Strom, TB .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3478-3485
[8]   CD28 AND T-CELL ANTIGEN RECEPTOR SIGNAL TRANSDUCTION COORDINATELY REGULATE INTERLEUKIN-2 GENE-EXPRESSION IN RESPONSE TO SUPERANTIGEN STIMULATION [J].
FRASER, JD ;
NEWTON, ME ;
WEISS, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1131-1134
[9]   CELLS MEDIATING ALLOGRAFT-REJECTION [J].
HALL, BM .
TRANSPLANTATION, 1991, 51 (06) :1141-1151
[10]  
HE YW, 1995, J IMMUNOL, V154, P1596